Product Information
IRBESARTAN 300 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.1530 per EA under NDC 43547037603. Its NADAC has been published 474 times since May 31, 2017.
Strength
300 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547037603
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IRBESARTANApproval Type
Generic (ANDA)
FDA Application
ANDA203071On Market Since
6/13/2016
Pharmacological Classes
Price Statistics
The NADAC for IRBESARTAN 300 MG TABLET has been published 474 times since May 31, 2017, and over the history we have for it it has declined 38.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1530 per EA |
|---|---|
| All-time high | $0.3794 (Jun 10, 2020) |
| All-time low | $0.1461 (Feb 18, 2026) |
| 52-week high | $0.1799 |
| 52-week low | $0.1461 |
| Median price | $0.2342 |
| Average price | $0.2440 |
| Largest weekly change | +33.1% (Aug 21, 2024) |
| Weeks tracked | 474 |
| Tracking since | May 31, 2017 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IRBESARTAN 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IRBESARTAN 300 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.1530 per EA (NDC 43547037603), effective Jun 24, 2026.
How has the price of IRBESARTAN 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for IRBESARTAN 300 MG TABLET has declined 38.5%. It has been tracked across 474 weekly CMS publications since May 31, 2017.
What are the highest and lowest recorded NADAC prices for IRBESARTAN 300 MG TABLET?
Since May 31, 2017, the NADAC for IRBESARTAN 300 MG TABLET has ranged from a low of $0.1461 (Feb 18, 2026) to a high of $0.3794 (Jun 10, 2020), with a median of $0.2342 per EA.
Are there cheaper alternatives to IRBESARTAN 300 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as IRBESARTAN 300 MG TABLET, but none are currently priced below it.
Who manufactures IRBESARTAN 300 MG TABLET?
IRBESARTAN 300 MG TABLET (NDC 43547037603) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification